Kaitlyn D’Onofrio

DocwireNews

In this week&rsquo;s rheumatology round-up, read about the latest updates on hydroxychloroquine and two arthritis drugs (tentatively) deemed effective in severe COVID-19, plus some news to raise a glass to (with a caveat).<a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/hydroxychloroquine-versus-sulfasalazine-how-do-these-ra-drugs-compare-in-risks-of-suicide-depression-psychosis/">Hydroxychloroquine Versus Sulfasalazine: How Do These RA Drugs Compare in Risks of Suicide, Depression, Psychosis?</a>A study found no correlation between hydroxychloroquine use and an increased risk for suicide, depression, or psychosis among patients with rheumatoid arthritis (RA) when compared with sulfasalazine. Hydroxychloroquine has garnered significant media attention during the COVID-19 pandemic, as the drug was initially thought to be a possible treatment for the virus (more on that in a bit). Nevertheless, questions about COVID-19, treatments, and the vaccine have been abundant among the community of patients with rheumatic diseases. However, short- and long-term analyses both found no significant risks for hydroxychloroquine users when compared to sulfasalazine users in depression, suicide/suicidal ideation, and psychosis.https://www.docwirenews.com/docwire-pick/rheumatology-picks/hydroxychloroquine-versus-sulfasalazine-how-do-these-ra-drugs-compare-in-risks-of-suicide-depression-psychosis/<a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/hydroxychloroquine-covid-19-study-paused-due-to-lack-of-participants/">Hydroxychloroquine COVID-19 Study Paused Due to Lack of Participants</a>A trial investigating the use of hydroxychloroquine to treat patients with COVID-19 has quietly closed enrollment after failure to recruit enough participants, according to a report. <a href="https://www.henryford.com/whip-covid-19">Henry Ford Health System&rsquo;s Will Hydroxychloroquine Impede or Prevent COVID-19</a>&nbsp;(WHIP COVID-19) trial was a randomized, double-blinded study that sought to recruit 3,000 volunteers, but according to&nbsp;<a href="https://www.bridgemi.com/michigan-health-watch/henry-ford-study-hydroxychloroquine-covid-quietly-shut-down">Bridge Michigan</a>, only 624 people signed up. The landing page for the WHIP&nbsp;<a href="https://www.docwirenews.com/docwire-pick/home-page-picks/the-pandemic-has-devastated-the-underserved-covid-19-and-the-undocumented-latino-community/">COVID-19</a>&nbsp;trial does not give a specific date for when enrollment was paused, but according to&nbsp;Bridge Michigan, it happened in late December, around Christmastime. The study was first announced on April 2, and enrollment opened on April 9, during a time that Detroit was experiencing a significant amount of COVID-19 cases.https://www.docwirenews.com/docwire-pick/rheumatology-picks/hydroxychloroquine-covid-19-study-paused-due-to-lack-of-participants/<a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/arthritis-drugs-tocilizumab-and-sarilumab-may-improve-covid-19-survival/">Arthritis Drugs Tocilizumab and Sarilumab May Improve COVID-19 Survival</a>RA drugs tocilizumab and sarilumab may improve outcomes in critically ill patients with COVID-19, according to a study. The study appeared in&nbsp;<a href="https://www.medrxiv.org/content/10.1101/2021.01.07.21249390v1.full-text">medRxiv</a> and is a preprint that has not yet been peer reviewed. Patients with COVID-19 who were in the intensive care unit (ICU) and had started organ support within 24 hours were randomized to receive either tocilizumab (8mg/kg), sarilumab (400mg), or standard care (control). For patients with available data at the time of analysis, the in-hospital mortality rates were: tocilizumab, 28.0%; sarilumab, 22.2%; and control, 35.8%. The pooled mortality rate for the two treatment groups was 27.3%.https://www.docwirenews.com/docwire-pick/rheumatology-picks/arthritis-drugs-tocilizumab-and-sarilumab-may-improve-covid-19-survival/<a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/drinking-alcohol-may-reduce-risk-for-rheumatoid-arthritis/">Drinking Alcohol May Reduce Risk for RA</a>Alcohol consumption may be associated with a decreased risk for developing RA, according to a recent study, and among people who smoke, a known risk factor for RA, drinking alcohol may have a protective effect. But don&rsquo;t make happy hour plans if cocktails aren&rsquo;t your thing. Despite the results of the study, the researchers did not recommend that non-drinkers begin drinking alcohol to reduce their odds of developing RA. Instead, they called for future research to help unveil a better understanding of why this relationship was observed.https://www.docwirenews.com/docwire-pick/rheumatology-picks/drinking-alcohol-may-reduce-risk-for-rheumatoid-arthritis/<a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/the-newly-crowned-best-diet-for-2021-may-reduce-risk-for-rheumatoid-arthritis-among-these-women/">The Newly Crowned Best Diet for 2021 May Reduce Risk for RA Among These Women</a>For the fourth year in a row, the Mediterranean diet has claimed the number one spot on U.S. News &amp; World Report&rsquo;s annual ranking of the best diets. The&nbsp;<a href="https://www.docwirenews.com/home-page-editor-picks/the-best-and-worst-diets-for-2020/">Mediterranean diet</a>&nbsp;ranked number one overall for 2021 and also garnered the first-place spots for best diets for healthy eating, easiest diets to follow, best diets for diabetes, best plant based diets, and best heart-healthy diets,&nbsp;<a href="https://www.usatoday.com/story/life/food-dining/2021/01/05/best-diet-2021-mediterranean-food-healthy-eating/4140496001/">USA Today</a>&nbsp;reports. And according to a study, among its many benefits, it may lower the risk of RA among women who were ever-smokers. When assessing a large cohort of women, no correlation was observed between Mediterranean diet adherence score and risk of RA. But when the group was stratified by smoking status, a higher score in ever-smokers was correlated with a reduced risk for RA.https://www.docwirenews.com/docwire-pick/rheumatology-picks/the-newly-crowned-best-diet-for-2021-may-reduce-risk-for-rheumatoid-arthritis-among-these-women/

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Rheum Round-up: Hydroxychloroquine, Arthritis and Alcohol, and more

Rheumatology

In this week’s rheumatology round-up, read about the latest updates on hydroxychloroquine and two arthritis drugs (tentatively) deemed effective in severe COVID-19, plus ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe